RefleXion Seeks FDA 510(k) Clearance for Anchor Point Tumor Tracking

RefleXion Medical submitted a 510(k) application to the FDA for Anchor Point, a tumor tracking technology—potential step toward more precise radiotherapy. (Exact details not reported in source.)

• RefleXion Medical seeks FDA clearance for Anchor Point, a tumor tracking feature that may integrate with its biology-guided radiotherapy platform.
• The submission is under review; FDA decision is pending, and technical specifications are not publicly disclosed.

RadPigeon summaries are original and for information only. They are not clinical advice.